urapidil has been researched along with Kidney Failure, Chronic in 3 studies
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Puttinger, H | 1 |
| Soleiman, A | 1 |
| Oberbauer, R | 1 |
| Hellberg, OK | 1 |
| Vlaho, M | 1 |
| Krawczyk, W | 1 |
| Steć, E | 1 |
3 other studies available for urapidil and Kidney Failure, Chronic
| Article | Year |
|---|---|
Regression of hypertensive nephropathy during three years of optimal blood pressure control.
Topics: Adrenergic alpha-Antagonists; Adult; Antihypertensive Agents; Biopsy; Echocardiography; Emergencies; | 2003 |
[Pharmacokinetics of urapidil in hypertensive patients with reduced kidney function].
Topics: Adult; Aged; Female; Humans; Hypertension, Renal; Kidney Failure, Chronic; Kinetics; Male; Middle Ag | 1983 |
[Urapidil (Ebrantil) use in patients on chronic hemodialysis].
Topics: Adult; Antihypertensive Agents; Female; Humans; Hypertension, Renal; Kidney Failure, Chronic; Male; | 1990 |